A5101415829- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Venous Thromboembolism Diagnosis and Management
- Colorectal Cancer Treatments and Studies
- Health Systems, Economic Evaluations, Quality of Life
- Advances in Oncology and Radiotherapy
- Sarcoma Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
- Cardiac tumors and thrombi
- Economic and Financial Impacts of Cancer
- Glioma Diagnosis and Treatment
- Organ Transplantation Techniques and Outcomes
- Neuroblastoma Research and Treatments
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Lymphoma Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Oral and Craniofacial Lesions
- Retinal and Optic Conditions
- Atrial Fibrillation Management and Outcomes
- Ocular Diseases and Behçet’s Syndrome
- Colorectal and Anal Carcinomas
- Genetic factors in colorectal cancer
- Cancer Diagnosis and Treatment
- Cleft Lip and Palate Research
Instituto Maimónides de Investigación Biomédica de Córdoba
2016-2025
Centro de Investigación Biomédica en Red de Cáncer
2019-2025
Hospital Plató
2023
Hospital Universitario Virgen del Rocío
2005-2022
Universidad de Sevilla
2018-2020
University of Córdoba
2016-2019
Hospital Universitario Reina Sofía
2013-2019
Instituto de Salud Carlos III
2016-2019
Instituto de Biomedicina de Sevilla
2018
Institución Universitaria Colegios de Colombia
2008-2017
Earlier studies evaluating the effect on quality of life (QoL) localized prostate cancer interventions included patients receiving adjuvant hormone therapy, which could have affected their outcomes. Our objective was to compare QoL impact three most common primary treatments who were not hormonal treatment.This a prospective study 435 treated with radical prostatectomy, external-beam radiotherapy, or brachytherapy. assessed before and after treatment Short Form-36 Expanded Prostate Cancer...
Summary Aim To develop a scale to assess the severity of hepatic encephalopathy using simple dichotomic items. Methods A list 48 items was created by selecting that are recognize and categorize; it applied thirty‐six cirrhotic in‐patients with episodic encephalopathy, in addition adapted‐West‐Haven Criteria Glasgow Coma Score. The underwent an item reduction process principal component analysis; metric characteristics were evaluated. Results Multiple neurological abnormalities observed...
178 Background: Survival of microsatellite instability (MSI) metastatic colorectal cancer (mCRC) patients (pts) has remarkably increased with immune checkpoint inhibitors (ICI). Here, we present our real-world data regarding the management and clinical outcomes a cohort 214 MSI-mCRC included in Spanish Group Treatment Digestive Tumors TTD Registry (RETUD). Methods: RETUD is national, multicenter registry for gastrointestinal tumors from Group. In this cross-sectional analysis evaluated pts...
Abstract To compare the effectiveness at ten years of follow-up radical prostatectomy, brachytherapy and external radiotherapy, in terms overall survival, prostate cancer-specific mortality biochemical recurrence. Cohort men diagnosed with localized cancer (T1/T2 low/intermediate risk) from Spanish hospitals, followed for 10 years. The treatment selection was decided jointly by patients physicians. Of 704 participants, 192 were treated open retropubic 317 125 I alone, 195 3D beam radiation....
Rectal cancer represents approximately 10% of cancers worldwide. Preoperative chemoradiotherapy increases complete pathologic response and local control, although it offers a poor advantage in survivorship sphincter saving compared with that radiotherapy alone. After preoperative chemoradiotherapy, 20% patients rectal achieve to the removed surgical specimen; this may be related better prognosis an improvement disease-free survival. However, biomarkers predict new targets are needed stratify...
Colorectal cancer (CRC) is the third most common worldwide. The standard treatment in locally advanced rectal preoperative radiation alone or combination with chemotherapy, followed by adjuvant chemotherapy. Rectal highly lethal, only 20% of patients showing a complete remission (by RECIST) after treatment, although they commonly show local systemic relapse likely due to its late detection and high chemotherapy resistance, among other reasons. Here, we explored role PAI1 (Serpin E1) through...
The objective of this study was to assess the influence ethnicity on toxicity in patients treated with dynamic arc radiation therapy (ART) for prostate cancer (PC).From June 2006 May 2012, 162 cT1-T3 cN0 cM0 PC were ART (primary diagnosis, n = 125; post-prostatectomy/brachytherapy biochemical recurrence, 26; adjuvant post-prostatectomy, 11) at 2 institutions. Forty-five Latin Americans and 117 Europeans. dose prescribed ranged between 68 Gy 81 Gy.The median age 69 years (range 43-87 years)....
TPS3651 Background: More than half of the mCRC are diagnosed in patients over 70 years. Around 15-20% do not qualify to receive polychemotherapy as first-line systemic therapy due age and/or comorbidities. The optimal treatment strategy for this group has been adequately defined. Regorafenib is a multikinase inhibitor that shown benefit overall and progression free survival (PFS) placebo with who have failed all approved standard therapies (Grothey et al. 2013). This trial will assess...
incidencia de anemia antes y durante la irradiación secundariamente influencia del tratamiento en corrección misma según el momento su aparición.